-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ABBV-916 in Alzheimer’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-916 in Alzheimer's Disease Drug Details: ABBV-916 is under development for the treatment of Alzheimer's...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Lorpucitinib in Familial Adenomatous Polyposis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Lorpucitinib in Familial Adenomatous Polyposis Drug Details:Lorpucitinib is under development for the treatment of familial adenomatous...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-4004280 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.VH-4004280 in Human Immunodeficiency Virus (HIV) Infections (AIDS)Drug Details:VH-4004280 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-3810109 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.VH-3810109 in Human Immunodeficiency Virus (HIV) Infections (AIDS) Drug Details:GSK-3810109 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – S-365598 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.S-365598 in Human Immunodeficiency Virus (HIV) Infections (AIDS) Drug Details:S-365598 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Debio-0123 in Astrocytoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Debio-0123 in AstrocytomaDrug Details:Debio-0123 (ADC-730) is under development for the treatment of advanced solid tumors, glioblastoma...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IO-108 in Merkel Cell Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.IO-108 in Merkel Cell CarcinomaDrug Details:IO-108 is under development for the treatment of solid tumors, merkel...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MAU-868 in Polyomavirus Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.MAU-868 in Polyomavirus InfectionsDrug Details:MAU-868 is under development for the treatment and prevention of BK virus...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-3739937 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.VH-3739937 in Human Immunodeficiency Virus (HIV) Infections (AIDS)Drug Details:GSK-3739937 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Dolutegravir + Fipravirimat) in Human Immunodeficiency Virus (HIV) Infections (AIDS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Dolutegravir + Fipravirimat) in Human Immunodeficiency Virus (HIV) Infections (AIDS)Drug Details:Dolutegravir in fixed dose combination with...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MRTX-9768 in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MRTX-9768 in Non-Small Cell Lung Cancer Drug Details:MRTX-9768 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-4011499A in Human Immunodeficiency Virus (HIV) Infections (AIDS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.VH-4011499A in Human Immunodeficiency Virus (HIV) Infections (AIDS) Drug Details:VH-4011499A is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ketamine in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ketamine in Binge Eating Disorder Drug Details:Ketamine is under development for the treatment of alcohol use...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ensomafusp Alfa in Marginal Zone B-cell Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ensomafusp alfa in Marginal Zone B-cell Lymphoma Drug Details:Ensomafusp alfa (RG-6076, RO-7227166) is under development for...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-4004280
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VH-4004280 Drug Details VH-4004280 is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – (dolutegravir + GSK3640254)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (dolutegravir + GSK3640254) Drug Details Dolutegravir in fixed dose combination with GSK-3640254 is under...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-4011499A
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VH-4011499A Drug Details VH-4011499A is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-3739937
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VH-3739937 Drug Details GSK-3739937 is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – VH-3810109
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry VH-3810109 Drug Details GSK-3810109 is under development for the treatment of human immunodeficiency virus...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – GSK-3640254
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GSK-3640254 Drug Details GSK-3640254 is under development for the treatment of human immunodeficiency virus...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.